As of 2026-09-18, the Relative Valuation of Adicet Bio Inc (ACET) is (256.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.01 USD, the upside of Adicet Bio Inc based on Relative Valuation is -2943.2%.
The range of the Relative Valuation is (248.76) - (247.70) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.0x - 23.4x | 22.2x |
| Forward P/E multiples | 23.5x - 28.9x | 26.2x |
| Fair Price | (248.76) - (247.70) | (256.17) |
| Upside | -2860.9% - -2849.2% | -2943.2% |
| Date | P/E |
| 2026-09-17 | -0.85 |
| 2026-09-16 | -0.85 |
| 2026-09-15 | -0.80 |
| 2026-09-14 | -0.92 |
| 2026-09-11 | -0.90 |
| 2026-09-10 | -0.90 |
| 2026-09-09 | -0.90 |
| 2026-09-08 | -0.92 |
| 2026-09-04 | -0.91 |
| 2026-09-03 | -0.89 |
| 2026-09-02 | -0.87 |
| 2026-09-01 | -0.87 |
| 2026-08-31 | -0.82 |
| 2026-08-28 | -0.86 |
| 2026-08-27 | -0.85 |
| 2026-08-26 | -0.85 |
| 2026-08-25 | -0.85 |
| 2026-08-24 | -0.84 |
| 2026-08-21 | -0.87 |
| 2026-08-20 | -0.89 |
| 2026-08-19 | -0.90 |
| 2026-08-18 | -0.86 |
| 2026-08-17 | -0.83 |
| 2026-08-14 | -0.79 |
| 2026-08-13 | -0.78 |
| 2026-08-12 | -0.78 |
| 2026-08-11 | -0.78 |
| 2026-08-10 | -0.77 |
| 2026-08-07 | -0.75 |
| 2026-08-06 | -0.75 |
| 2026-08-05 | -0.87 |
| 2026-08-04 | -0.87 |
| 2026-08-03 | -0.87 |
| 2026-07-31 | -0.86 |
| 2026-07-30 | -0.86 |
| 2026-07-29 | -0.78 |
| 2026-07-28 | -0.77 |
| 2026-07-27 | -0.76 |
| 2026-07-24 | -0.74 |
| 2026-07-23 | -0.80 |
| 2026-07-22 | -0.81 |
| 2026-07-21 | -0.77 |
| 2026-07-20 | -0.75 |
| 2026-07-17 | -0.77 |
| 2026-07-16 | -0.78 |
| 2026-07-15 | -0.82 |
| 2026-07-14 | -0.83 |
| 2026-07-13 | -0.81 |
| 2026-07-10 | -0.83 |
| 2026-07-09 | -0.84 |